Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date (Descending) Status
68001-0286-39 68001-0286 Leucovorin Calcium Leucovorin 20.0 mg/mL Ancillary Therapy Chemoprotective Antidote Intramuscular, Intravenous July 1, 2016 Feb. 1, 2021 No Longer Used
42292-0051-05 42292-0051 Erlotinib hydrochloride Erlotinib Hydrochloride 25.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral May 28, 2019 Jan. 31, 2021 No Longer Used
42292-0053-05 42292-0053 Erlotinib hydrochloride Erlotinib Hydrochloride 150.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral May 28, 2019 Jan. 31, 2021 No Longer Used
57894-0421-01 57894-0421 Siltuximab Sylvant 400.0 mg/1 Immunotherapy Monoclonal Antibody Interleukin-6 Antagonists Intravenous April 1, 2014 Jan. 31, 2021 No Longer Used
57894-0420-01 57894-0420 Siltuximab Sylvant 100.0 mg/1 Immunotherapy Monoclonal Antibody Interleukin-6 Antagonists Intravenous April 23, 2014 Jan. 31, 2021 No Longer Used
25021-0236-04 25021-0236 Topotecan Topotecan 1.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Dec. 15, 2014 Jan. 31, 2021 No Longer Used
45963-0624-58 45963-0624 Gemcitabine Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous April 12, 2016 Jan. 31, 2021 No Longer Used
45963-0640-77 45963-0640 Busulfan Busulfan 6.0 mg/mL Chemotherapy Alkylating Agent Alkylsulfonate Intravenous Jan. 4, 2018 Jan. 31, 2021 No Longer Used
50090-0294-09 50090-0294 METHOTREXATE Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral June 29, 2016 Jan. 31, 2021 In Use
59148-0047-91 59148-0047 Busulfan Busulfex 6.0 mg/mL Chemotherapy Alkylating Agent Alkylsulfonate Intravenous Feb. 13, 2015 Jan. 31, 2021 No Longer Used
60505-6113-06 60505-6113 GEMCITABINE HYDROCHLORIDE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 20, 2018 Jan. 31, 2021 No Longer Used
60505-6114-00 60505-6114 GEMCITABINE HYDROCHLORIDE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 20, 2018 Jan. 31, 2021 No Longer Used
60505-6115-02 60505-6115 GEMCITABINE HYDROCHLORIDE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 20, 2018 Jan. 31, 2021 No Longer Used
00009-0796-01 00009-0796 Methylprednisolone Sodium Succinate Solu-Medrol Hormonal Therapy Adrenal Glucocorticoid Corticosteroid April 2, 1959 Jan. 31, 2021 No Longer Used
00051-0022-21 00051-0022 Dronabinol Marinol 5.0 mg/1 Ancillary Therapy Antiemetic CB1/CB2 Oral July 13, 2010 Jan. 31, 2021 No Longer Used
60505-3877-03 60505-3877 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 25, 2015 Jan. 31, 2021 No Longer Used
60505-3877-09 60505-3877 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 25, 2015 Jan. 31, 2021 No Longer Used
43063-0560-02 43063-0560 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral April 4, 2016 Jan. 18, 2021 No Longer Used
43063-0560-03 43063-0560 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral April 4, 2016 Jan. 18, 2021 No Longer Used
43063-0560-04 43063-0560 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral April 4, 2016 Jan. 18, 2021 No Longer Used
43063-0560-05 43063-0560 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Feb. 12, 2015 Jan. 18, 2021 No Longer Used
43063-0560-06 43063-0560 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Feb. 12, 2015 Jan. 18, 2021 No Longer Used
43063-0560-10 43063-0560 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Feb. 12, 2015 Jan. 18, 2021 No Longer Used
43063-0560-20 43063-0560 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Feb. 12, 2015 Jan. 18, 2021 No Longer Used
59630-0222-07 59630-0222 Naldemedine SYMPROIC 0.2 mg/1 Ancillary Therapy Opioid Antagonist Oral July 5, 2018 Dec. 31, 2020 No Longer Used
59630-0222-30 59630-0222 Naldemedine SYMPROIC 0.2 mg/1 Ancillary Therapy Opioid Antagonist Oral July 5, 2018 Dec. 31, 2020 No Longer Used
59630-0222-90 59630-0222 Naldemedine SYMPROIC 0.2 mg/1 Ancillary Therapy Opioid Antagonist Oral July 5, 2018 Dec. 31, 2020 No Longer Used
00006-0464-05 00006-0464 Aprepitant Emend 40.0 mg/1 Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Oral March 26, 2003 Dec. 31, 2020 In Use
00006-0464-10 00006-0464 Aprepitant Emend 40.0 mg/1 Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Oral March 26, 2003 Dec. 31, 2020 In Use
60429-0925-90 60429-0925 Imatinib Mesylate Imatinib Mesylate 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Dec. 30, 2016 Dec. 31, 2020 No Longer Used
25021-0814-67 25021-0814 Leucovorin Calcium Leucovorin Calcium 100.0 mg/10mL Ancillary Therapy Chemoprotective Antidote Intramuscular, Intravenous Dec. 1, 2013 Dec. 31, 2020 In Use
63187-0657-30 63187-0657 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Dec. 1, 2018 Dec. 31, 2020 In Use
63187-0657-60 63187-0657 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Dec. 1, 2018 Dec. 31, 2020 In Use
63187-0657-90 63187-0657 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Dec. 1, 2018 Dec. 31, 2020 In Use
00781-5238-06 00781-5238 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Nov. 19, 2011 Dec. 31, 2020 In Use
00781-5239-06 00781-5239 Ondansetron Ondansetron 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Nov. 19, 2011 Dec. 31, 2020 No Longer Used
00781-5239-64 00781-5239 Ondansetron Ondansetron 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Aug. 13, 2007 Dec. 31, 2020 No Longer Used
48102-0046-01 48102-0046 dexamethasone Dexamethasone 0.75 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 1, 2018 Dec. 31, 2020 In Use
48102-0048-01 48102-0048 dexamethasone Dexamethasone 6.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 1, 2018 Dec. 31, 2020 In Use
63187-0482-30 63187-0482 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Feb. 2, 2015 Dec. 31, 2020 In Use
63187-0482-60 63187-0482 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Feb. 2, 2015 Dec. 31, 2020 In Use
63187-0482-90 63187-0482 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Feb. 2, 2015 Dec. 31, 2020 In Use
00143-9740-01 00143-9740 Prednisone Prednisone 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug. 3, 2009 Dec. 31, 2020 No Longer Used
00143-9738-10 00143-9738 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug. 3, 2009 Dec. 31, 2020 No Longer Used
63739-0269-42 63739-0269 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral May 8, 2019 Dec. 31, 2020 In Use
57962-0560-71 57962-0560 Ibrutinib IMBRUVICA 560.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor Bruton's Tyrosine Kinase (Btk) /BCR Oral Feb. 6, 2019 Dec. 31, 2020 In Use
70518-2314-01 70518-2314 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 20, 2019 Dec. 22, 2020 In Use
76189-0113-18 76189-0113 Brigatinib Alunbrig 30.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor ALK/ROS1/ EGFR Oral April 28, 2017 Dec. 12, 2020 No Longer Used
76189-0113-21 76189-0113 Brigatinib Alunbrig 30.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor ALK/ROS1/ EGFR Oral April 28, 2017 Dec. 12, 2020 No Longer Used
00069-4033-01 00069-4033 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous March 5, 2013 Nov. 30, 2020 In Use

Found 10,000 results in 3 milliseconds — Export these results